DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR VOLTAREN-XR
Clinical Trials for Voltaren-xr
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00171691 | Safety of Diclofenac Sodium Gel in Knee Osteoarthritis | Completed | Novartis | Phase 3 | 2004-10-01 | This study will test the efficacy and safety of topical Voltaren in the treatment of knee osteoarthritis. |
| NCT00276419 | Treatment of Breast Pain Using A Medication (Diclofenac) Applied to the Skin | Terminated | Mayo Clinic | Phase 2/Phase 3 | 2005-06-01 | The study was a randomized, double-blinded, crossover trial of topical diclofenac and placebo (10 weeks of each) for the treatment of noncyclic breast pain. |
| NCT00310908 | Comparison Between Tramadol Hcl and Other Analgesics in the Treatment of Renal Colic | Completed | Grumental | Phase 4 | 2006-09-01 | The purpose of this study is to determine whether Tramadol Hcl is as effective as Voltaren a non-steroidal antiinflammatory drug, and Dipyrone in amelioration of the pain caused by acute renal colic. |
| NCT00310908 | Comparison Between Tramadol Hcl and Other Analgesics in the Treatment of Renal Colic | Completed | Hadassah Medical Organization | Phase 4 | 2006-09-01 | The purpose of this study is to determine whether Tramadol Hcl is as effective as Voltaren a non-steroidal antiinflammatory drug, and Dipyrone in amelioration of the pain caused by acute renal colic. |
| NCT00523120 | Topical Voltaren in Otitis Externa | Terminated | Sieff Medical Center | Phase 2 | 2008-09-01 | Voltaren being a Non-steroidal anti-inflammatory drug (NSAID) drug may be used as a single drug therapy in otitis externa being both therapeutic and analgesic thus reducing consumption of oral analgesia. |
| NCT00715091 | Effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) on RAdiographic Damage in Ankylosing Spondylitis | Completed | Charite University, Berlin, Germany | Phase 4 | 2008-09-01 | This is a randomised, controlled, multi-centre clinical trial on AS patients. Experimental intervention: continuous (daily) treatment with diclofenac cholestyramine 150 mg (Voltaren Resinate), divided into 75mg Voltaren twice dailyControl intervention: treatment on-demand (as needed) with diclofenac-cholestyramine 75 to 150 mg (Voltaren Resinate). The treatment strategy of the control intervention (on-demand) reflects current clinical practice in AS. Duration of intervention per patient: 2 years Follow-up per patient: safety assessment 3 months after termination of the trial. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Voltaren-xr
Condition Name
Clinical Trial Locations for Voltaren-xr
Trials by Country
Clinical Trial Progress for Voltaren-xr
Clinical Trial Phase
Clinical Trial Sponsors for Voltaren-xr
Sponsor Name
